Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...
The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...
The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...
In cancer patients with brain metastases and type 2 diabetes, those using GLP-1 drugs had a 37% lower risk of death over 3 years. Significant mortality benefits were linked to semaglutide and ...
GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.
With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...
Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.
New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 diabetes compared to other diabetes medications.
The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that ...
Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...
While the drug still offers major benefits for blood sugar, weight loss and heart health, those taking the drugs had a higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results